S&P Equity Research initiates coverage on Genomic Health Inc. (Nasdaq: GHDX) with a Hold. Price target $18.

S&P ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE